Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription-translation assay system for evaluation of translation inhibitors

Journal of Microbiological Methods

Volumn 90, Issue 3, 2012, Pages 256-261

  Fyfe, Corey ^a   Sutcliffe, Joyce A ^a   Grossman, Trudy H ^a  

^a Tetraphase Pharmaceuticals Inc   (United States)

Author keywords

Coupled transcription translation assay; Pseudomonas aeruginosa; S30 extract; Translation antibiotics

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CYCLOHEXIMIDE; DOXYCYCLINE; ERYTHROMYCIN; FIREFLY LUCIFERASE; HYGROMYCIN B; LEVOFLOXACIN; LINCOMYCIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PAROMOMYCIN; PUROMYCIN; RIFAMPICIN; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; THIOSTREPTON; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; ESCHERICHIA COLI; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION TRANSLATION ASSAY;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; GENES, REPORTER; LUCIFERASES, FIREFLY; MICROBIAL SENSITIVITY TESTS; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84864105785     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.05.018     Document Type: Article

References (19)

1. Alvarez M., Mendoza M.C. Epidemiological survey of genes encoding aminoglycoside phosphotransferase APH (3') I and APH (3') II using DNA probes. J. Chemother. 1992, 4:203-210.
2. Butler M.S., Cooper M.A. Antibiotics in the clinical pipeline in 2011. J. Antibiot. 2011, 64:413-425.
3. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI Document M07-A8 2009, Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA. Eighth Edition.
4. Dandliker P.J., Pratt S.D., Nilius A.M., Black-Schaefer C., Ruan X., Towne D.L., Clark R.F., Englund E.E., Wagner R., Weitzberg M., Chovan L.E., Hickman R.K., Daly M.M., Kakavas S., Zhong P., Cao Z., David C.A., Xuei X., Lerner C.G., Soni N.B., Bui M., Shen L.L., Cai Y., Merta P.J., Saiki A.Y.C., Beutel B.A. Novel antibacterial class. Antimicrob. Agents Chemother. 2003, 47:3831-3839.
5. Eustice D.C., Feldman P.A., Slee A.M. The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 1988, 150:965-971.
6. Infectious Diseases Society of America The 10×'20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 2010, 50:1081-1083.
7. Kang Y., Son M.S., Hoang T.T. One step engineering of T7-expression strains for protein production. Protein Expr. Purif. 2007, 55(2):325-333.
8. Kim T.-W., Keum J.-W., Oh I.-S., Choi C.-Y., Park C.-G., Kim D.-M. Simple procedures for the construction of a robust and cost-effective cell-free protein synthesis system. J. Biotechnol. 2006, 126:554-561.
9. Kim T.-W., Kim H.-C., Oh I.-S., Kim D.-M. A highly efficient and economical cell-free protein synthesis system using the S12 extract of Escherichia coli. Biotechnol. Bioprocess Eng. 2008, 13:464-469.
10. Kohrer C., Mayer C., Grobner P., Piendl W. Use of T7 RNA polymerase in an optimized Escherichia coli coupled in vitro transcription-translation system: application in regulatory studies and expression of long transcription units. Eur. J. Biochem. 1996, 236:234-239.
11. Kumar A., Chua K., Schweizer H.P. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob. Agents Chemother. 2006, 50:3460-3463.
12. Li X.-Z., Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004, 64:159-204.
13. Liu D.V., Zawada J.F., Swartz J.R. Streamlining Escherichia coli S30 extract preparation for economical cell-free protein synthesis. Biotechnol. Prog. 2005, 21:460-465.
14. Ma R., Yang Z., Huang L., Zhu X., Kai L., Cai J., Wang X., Xu Z. Construction of an efficient Escherichia coli cell-free system for in vitro expression of several kinds of protein. Eng. Life Sci. 2010, 10:333-338.
15. Murray R.W., Melchior E.P., Hagadorn J.C., Marotti K.R. Staphylococcus aureus cell extract transcription-translation assay: firefly luciferase reporter system for evaluating protein translation inhibitors. Antimicrob. Agents Chemother. 2001, 45:1900-1904.
16. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 2003, 67:593-656.
17. Sohmen D., Harms J.M., Schlünzen F., Wilson D.N. Enhanced snapshot: antibiotic inhibition of protein synthesis II. Cell 2009, 139(1):212-212.e1.
18. Sutcliffe J.A. Antibiotics in development targeting protein synthesis. Ann. N.Y. Acad. Sci. 2011, 1241:122-152.
19. Wilson D.N. The A-Z of bacterial translation inhibitors. Crit. Rev. Biochem. Mol. Biol. 2009, 44:393-433.